| [1] |
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2):74-108.
|
| [2] |
陈规划，张琪．干细胞在肝移植中的应用现状及展望[J/CD]．中华肝脏外科手术学电子杂志，2012, 1(2):70-73.
|
| [3] |
Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism[J]. Dev Cell, 2010, 18(6):884-901.
|
| [4] |
Hung SC, Deng WP, Yang WK, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging[J]. Clin Cancer Res, 2005, 11(21):7749-7756.
|
| [5] |
Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment[J]. Cancer Metastasis Rev, 2010, 29(2):249-261.
|
| [6] |
Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans[J]. Hepatology, 2000, 32(1):11-16.
|
| [7] |
Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium[J]. Gastroenterology, 2001, 120(2):534-544.
|
| [8] |
Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells[J]. J Clin Invest, 2002, 109(10):1291-1302.
|
| [9] |
Amer ME, El-Sayed SZ, El-Kheir WA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells[J]. Eur J Gastroenterol Hepatol, 2011, 23(10):936-941.
|
| [10] |
唐甜，李红，薛冰，等．骨髓间充质干细胞对HepG2肝癌细胞增殖的影响[J]．南京医科大学学报：自然科学版，2012, 32(5):604-608.
|
| [11] |
Li GC, Ye QH, Xue YH, et al. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line[J]. Cancer Sci, 2010, 101(12):2546-2553.
|
| [12] |
Hernanda PY, Pedroza-Gonzalez A, van der Laan LJ, et al. Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma[J]. Carcinogenesis, 2013, 34(10):2330-2340.
|
| [13] |
李国才，武金才，孙冰生，等．骨髓间充质干细胞对人肝癌细胞系MHCC97-H增殖能力的影响[J]．中华实验外科杂志，2008, 25(7):823-825.
|
| [14] |
邵志红，王培军，李铭华，等．大鼠骨髓间充质干细胞移植对Walker-256肝癌生长影响的实验研究[J]．中华医学杂志，2009, 89(7):491-496.
|
| [15] |
乔玲，赵铁军，山长亮，等．人间充质干细胞抑制肝癌细胞增殖的作用及其基因表达谱分析[J]．中国生物化学与分子生物学报，2007, 23(12):1037-1044.
|
| [16] |
Abdel Aziz MT, Khaled HM, El Hindawi A, et al. Effect of mesenchymal stem cells and a novel curcumin derivative on Notch1 signaling in hepatoma cell line[J]. Biomed Res Int, 2013:129629.
|
| [17] |
姜晗昉，任军．小鼠骨髓间充质干细胞接种小鼠肝癌组织诱发肝癌细胞坏死[J]．北京大学学报：医学版，2008, 40(5):453-458.
|
| [18] |
Li T, Song B, Du X, et al. Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study[J]. Eur J Med Res, 2013(18):34.
|
| [19] |
Xie C, Xie DY, Lin BL, et al. Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway[J]. Br J Cancer, 2013, 109(5):1198-1205.
|
| [20] |
Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets[J]. Nat Med, 2011, 17(11):1359-1370.
|
| [21] |
Trkov S, Eng G, Di Liddo R, et al. Micropatterned three-dimensional hydrogel system to study human endothelial-mesenchymal stem cell interactions[J]. J Tissue Eng Regen Med, 2010, 4(3):205-215.
|
| [22] |
宋浩，纪卫政，邰沁文，等．骨髓间充质干细胞对肝癌模型大鼠血管形成的影响[J]．中国组织工程研究，2012, 16(14):2481-2486.
|
| [23] |
Deng Y, Yi S, Wang G, et al. Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1[J]. Stem Cells Dev, 2014, DOI: 10.1089/scd.2013.0559[Epub ahead of print]. |
| [24] |
Barzilay R, Melamed E, Offen D. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible[J]. Stem Cells, 2009, 27(10):2509-2515.
|
| [25] |
Raicevic G, Rouas R, Najar M, et al. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells[J]. Hum Immunol, 2010, 71(3):235-244.
|
| [26] |
Waterman RS, Tomchuck SL, Henkle SL, et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype[J]. PLoS One, 2010, 5(4):e10088.
|
| [27] |
Fürst G, Schulte am Esch J, Poll LW, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience[J]. Radiology, 2007, 243(1):171-179.
|
| [28] |
王红梅，赵秀娟，乔振华．晚期肝癌化疗结合骨髓间充质干细胞输注疗效观察[J]．临床医药实践，2009, 18(5):327-329.
|
| [29] |
刘铮，马宏，史娟，等．间充质干细胞介导的TRAIL可控性表达及其杀伤人肝癌细胞的活性研究[J]．中华医学杂志，2011, 91(8):544-548.
|
| [30] |
Mohr A, Lyons M, Deedigan L, et al. Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model[J]. J Cell Mol Med, 2008, 12(6B):2628-2643.
|